Corcept Therapeutics
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13.3M | 2,168 | 50.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4.7M | 2,168 | 17.7% |
| Food and Beverage | $2.6M | 102,336 | 10.0% |
| Consulting Fee | $2.6M | 1,135 | 9.9% |
| Travel and Lodging | $1.5M | 3,875 | 5.8% |
| Honoraria | $1.4M | 560 | 5.4% |
| Grant | $152,052 | 21 | 0.6% |
| Space rental or facility fees (teaching hospital only) | $77,030 | 35 | 0.3% |
| Education | $13,491 | 605 | 0.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $7,930 | 6 | 0.0% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $3,500 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CORT125134-552 | $3.3M | 0 | 210 |
| CORT125134-550 | $2.9M | 0 | 71 |
| Study 550 | $2.5M | 0 | 63 |
| CORT125134-455 | $1.1M | 0 | 441 |
| CORT125281-601 | $858,185 | 0 | 171 |
| CORT118335-876 | $476,204 | 0 | 153 |
| CORT125134-452 | $383,402 | 0 | 107 |
| Study 500 | $224,230 | 0 | 19 |
| Study 451 | $197,382 | 0 | 27 |
| Study 700 | $174,731 | 0 | 11 |
| CORT125134-456 | $165,233 | 0 | 56 |
| CORT118335-877 | $132,430 | 0 | 42 |
| C1073-500 Phase 1 Study of Mifepristone in Combination with Eribulin in Patients with Locally AdvancedMetastatic Breast Cancer or Other Specified Solid Tumors, with a Dose Expansion Cohort in Patients with Triple Negative Breast Cancer | $130,132 | 0 | 5 |
| CORT125134-551 | $124,841 | 0 | 4 |
| CORT125134-553 | $85,048 | 0 | 19 |
| CORT125134-451 Cushing's Syndrome | $84,948 | 0 | 20 |
| FKBP5-700 | $73,069 | 0 | 5 |
| CORT125134-451 | $71,146 | 0 | 16 |
| MONARCH STUDY 862 | $67,174 | 33 | 310 |
| Study 601 | $63,315 | 0 | 10 |
| Study 860 | $35,700 | 0 | 2 |
| CATALYST | $33,568 | 22 | 167 |
| Study 455 | $28,372 | 16 | 126 |
| C1073-38 | $26,769 | 0 | 1 |
| CORT 125134-451 | $21,623 | 0 | 2 |
| C1073-500 | $13,964 | 0 | 2 |
| Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome | $12,520 | 0 | 1 |
| Study 876 | $12,095 | 10 | 69 |
| CORT FKBP5-700 | $11,277 | 0 | 1 |
| STOMP-CSC | $7,500 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Gaja Andzel, M.d, M.D | Internal Medicine | Yucaipa, CA | $55,575 | $0 |
| Lawrence Kirschner, M.d, M.D | Endocrinology, Diabetes & Metabolism | Columbus, OH | $49,590 | $0 |
| David Gamble, N.p, N.P | Nurse Practitioner | Salt Lake City, UT | $49,244 | $0 |
| James Findling, Md, MD | Endocrinology, Diabetes & Metabolism | Menomonee Falls, WI | $48,678 | $0 |
| Dr. Charalambos Demetri, Do, DO | Endocrinology, Diabetes & Metabolism | Statesville, NC | $48,559 | $0 |
| Ned Kalin, Md, MD | Psychiatry | Madison, WI | $47,050 | $0 |
| Dr. Daniel Einhorn, M.d, M.D | Endocrinology, Diabetes & Metabolism | La Jolla, CA | $45,083 | $0 |
| Daniel Tung, M.d, M.D | Specialist | Houston, TX | $44,843 | $0 |
| Amir Hamrahian, Md, MD | Endocrinology, Diabetes & Metabolism | Cleveland, OH | $43,657 | $0 |
| Dr. Joselito Cabaccan, Md, MD | Endocrinology, Diabetes & Metabolism | San Jose, CA | $43,573 | $0 |
| Unknown Provider | — | — | $41,300 | $0 |
| Vivian Fonseca, Md, MD | Endocrinology, Diabetes & Metabolism | New Orleans, LA | $41,210 | $0 |
| Laurence Katznelson, Md, MD | Endocrinology, Diabetes & Metabolism | Los Angeles, CA | $40,504 | $0 |
| Michael Raymund Gonzales, Md, MD | Endocrinology, Diabetes & Metabolism | Reno, NV | $40,307 | $0 |
| Dr. David Pickering, D.o, D.O | Endocrinology, Diabetes & Metabolism | Parkersburg, WV | $37,345 | $0 |
| Dr. Julie Silverstein, Md, MD | Endocrinology, Diabetes & Metabolism | Saint Louis, MO | $36,234 | $0 |
| Dr. Vidhyalakshmi Kannan, Md, MD | Internal Medicine | Mesa, AZ | $34,499 | $0 |
| Dr. David Escalante, Md, MD | Emergency Medicine | Jellico, TN | $34,001 | $0 |
| Michael Thomas, Md, MD | Endocrinology, Diabetes & Metabolism | Columbus, OH | $33,715 | $0 |
| Dr. Jeffrey Unger, M.d, M.D | Endocrinology, Diabetes & Metabolism | Chino, CA | $32,409 | $0 |
| Dr. Sergio Rovner, M.d, M.D | Endocrinology, Diabetes & Metabolism | El Paso, TX | $31,647 | $0 |
| Minou Tran, M.d, M.D | Endocrinology, Diabetes & Metabolism | Pico Rivera, CA | $30,462 | $0 |
| Dr. Mark Borchelt, Md, Face, MD, FACE | Endocrinology, Diabetes & Metabolism | Gulfport, MS | $30,411 | $0 |
| Jaiwant Rangi, Md, Face, MD, FACE | Endocrinology, Diabetes & Metabolism | Folsom, CA | $28,897 | $0 |
| Abraham Vandiver, Fnp, FNP | Registered Nurse | Escondido, CA | $28,562 | $0 |
About Corcept Therapeutics
Corcept Therapeutics has made $26.5M in payments to 20,973 healthcare providers, recorded across 112,910 transactions in the CMS Open Payments database. In 2024, the company paid $4.2M. The top product by payment volume is Korlym ($17.3M).
Payments were distributed across 184 medical specialties. The top specialty by payment amount is Endocrinology, Diabetes & Metabolism ($7.3M to 2,656 doctors).
Payment categories include: Food & Beverage ($2.6M), Consulting ($2.6M), Research ($13.3M), Travel & Lodging ($1.5M).
Corcept Therapeutics is associated with 1 products in the CMS Open Payments database.